NAZIRA USMANOVA: Open Payments
NPI 1902444979 · BOYS TOWN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 22 payments from 8 companies in 2025. Trend: 2023 $157 · 2024 $327 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $300 |
| Supernus Pharmaceuticals, Inc. | 4 | $107 |
| ABBVIE INC. | 4 | $100 |
| Janssen Pharmaceuticals, Inc | 2 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $22 |
Products named: FANAPT, HETLIOZ, Qelbree, VRAYLAR, SPRAVATO, CAPLYTA, AUSTEDO XR, Auvelity.
Industry payments across NE — which companies pay providers there.
